ArticleEJNMMI research2025

AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysis.

Tristan Ruhwedel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.